by mozay | Mar 25, 2026 | team
Jeff Mathers is a commercial and marketing leader with deep experience across healthcare, medtech-adjacent, and regulated industries. He currently leads go-to-market strategy and commercialization efforts at Polus Health, focused on accelerating clinical trial...
by mozay | Mar 25, 2026 | team
Kyle Fogarty is a founder and clinical research leader with deep experience across clinical trials, healthcare, and medical education. He is the founder of Polus Health, where he focuses on accelerating clinical trial enrollment and improving site performance across...
by mozay | Jan 28, 2026 | Uncategorized
The Limits of Precision in Modern Clinical Trials Introduction: The Technology Paradox Clinical trials have never had access to more advanced technology, yet enrollment has rarely been more challenging. Across therapeutic areas, and particularly in retina, sponsors...
by mozay | Jan 28, 2026 | Uncategorized
Over 50%. That’s the current screen failure rate across more than 350 active clinical trials in the retina space. Half of all potential participants never move past the initial screening phase. This wasn’t always the case, but it has become the new reality and a stark...
